Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 35,643 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Oct 1 to Oct 5, 2026 · Filed Oct 5, 2026

From Oct 1 to Oct 5, 2026, Rubinstein Julie (President and COO) sold 35,643 Adaptive Biotechnologies Corporation shares at an average US$28.46 for US$1.01M under a trading plan, leaving 377,802 shares. Filed Oct 5, 2026 (Form 4).

Sold
35,643 shares
Price
US$28.46 average (US$27.57 to US$29.67)
Value
US$1.01M
Holding after
377,802 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 1, 2026Common StockSale6,081US$27.57383,602Direct
Oct 1, 2026Common StockSale5,800US$28.56377,802Direct
Oct 2, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 2, 2026Common StockSale11,881US$28.13377,802Direct
Oct 5, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 5, 2026Common StockSale6,699US$28.82382,984Direct
Oct 5, 2026Common StockSale5,182US$29.67377,802Direct

Source

View original at SEC

Related